Using Multicellular Tumor Spheroids to Test PET Tracers for Breast Cancer Treatment
Author Information
Author(s): Monazzam Azita, Josephsson Raymond, Blomqvist Carl, Carlsson Jörgen, Långström Bengt, Bergström Mats
Primary Institution: Uppsala University Hospital
Hypothesis
Can multicellular tumor spheroids (MTS) effectively screen PET tracers for monitoring chemotherapy response in breast cancer?
Conclusion
The study demonstrates that MTS combined with SASDM and PET tracers can effectively monitor the response to anticancer drugs in breast cancer treatment.
Supporting Evidence
- The study found that FLT was more sensitive than other PET tracers in monitoring therapy effects.
- Drugs like paclitaxel and doxorubicin significantly inhibited growth and reduced FLT uptake.
- The methodology allows for accurate assessment of viable cell volume in spheroids.
Takeaway
Researchers used special cell clusters to test how well different PET scans can show if breast cancer treatments are working.
Methodology
The study involved growing multicellular tumor spheroids from breast cancer cells and exposing them to various anticancer drugs while measuring PET tracer uptake.
Limitations
The study only used one type of breast cancer cell line, which may limit the generalizability of the findings.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website